Please login to the form below

Not currently logged in
Email:
Password:

Ipsos promotes Jackie Ilacqua to global head of syndicated services

Will retain role as president of global oncology

Ipsos Healthcare Jackie Ilacqua Ipsos Healthcare – the healthcare focused subsidiary of market research company Ipos – has added global head of syndicated services to Jackie Ilacqua's existing role as president of global oncology.

In her new combined position she will lead the company's syndicated and custom oncology business around the globe.

Ilacqua's promotion comes just over a year after she joined Ipsos Healthcare from Synovate Healthcare, where she was a senior vice president.

During her time as president of global oncology, she has grown Ipsos' Global Oncology Monitor from seven countries to 21, created a range of new products, and worked with major manufacturers of oncology medicines.

“Jackie brings to this combined role an impressive blend of market research knowledge, healthcare expertise and true strategic flair,” said Michael Spedding, CEO of Ipsos Healthcare.

“She is perfectly placed to lead the charge in adding value to existing services, and extending our portfolio to meet clients' changing needs.”

22nd April 2013

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics